Byline: Melissa Rohman
-
First-year Medical Student Shares Her First Impressions of Feinberg
Kayla Giger, a first-year medical student, shared her thoughts about her first week of medical school and, in the future, working with Feinberg’s Education Centered Medical Home clinics.
-
New Medical Student Reflects on His First Week at Feinberg
Erick Masias, a first-year medical student, reflected on his first week at Feinberg and shared what he’s looking forward to over the next four years.
-
Uncovering Similarities Between Prostate Cancer Genomes
Genomic alterations in prostate cancer therapeutic targets were found to be similar between African American and European American men, suggesting that existing precision medicine approaches could equally benefit both groups if applied equitably, according to a recent study.
-
Northwestern Takes on COVID-19 Antibody Testing
At Northwestern Medicine, various COVID-19 antibody testing efforts have been underway since the beginning of the pandemic.
-
Assessing Risk Factors in Critically Ill COVID-19 Patients
Certain factors are associated with increased risk of death in critically ill COVID-19 patients, according to recent Northwestern Medicine studies.
-
Drug Proves Ineffective in Slowing Diabetic Kidney Disease
A drug commonly used to reduce serum urate levels proved ineffective in slowing disease progression in patients with diabetic kidney disease, according to a recent study.
-
Uncovering the Genetic Link Behind the Development of COPD
A Northwestern Medicine study found that inducing inflammation in lung epithelial cells contributes to the development of chronic obstructive pulmonary disease.
-
Scientists Develop New Method to Trace Cell Lineage
Northwestern Medicine scientists have developed a novel cell lineage tracing method that can better determine the origin of mammalian neuron populations from progenitor cells.
-
Prioritizing Health Equity
As health inequities affect vulnerable populations, healthcare organizations must shift to a health equity centered, population health approach, according to a recent position paper from the National Academy of Medicine.
-
Protein May Improve Immunotherapy for Medulloblastoma
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
